NON PROFIT
1 min.Read

ACC Cardio-oncology Course Equips Clinicians, Researchers with Tools to Improve Cardiovascular Care for Cancer Patients

The conference aims to ensure the care team stays at the leading edge of this evolving field

The American College of Cardiology (ACC) will host the annual Advancing the Cardiovascular Care of the Oncology Patient course on April 14-16, 2023, in Washington, DC. The course is intended for all members of the interprofessional care team—including cardiologists, oncologists, pharmacists and nurses—and aims to equip the global cardio-oncology community with the tools they need to improve patient care.

Ana Barac, MD, PhD, FACC, and Bonnie Ky, MD, MSCE, FACC, will serve as co-directors for the course, which will be available both in-person and online. The course will bring together clinicians and researchers from across the globe to share emerging strategies and best practices for managing the cardiovascular health of cancer patients.

“I am proud to say that the ACC course has set the standards for cardio-oncology education, including joint presentations of oncologists and cardiologists modeling real-life patient care and collaboration across CV and oncology teams,” Barac said. “This year, our theme is collaboration and innovation through science and for our patients. I am very excited about the first-ever joint sessions with the American Society of Clinical Oncology and the American Society of Hematology that are a testament of the commitment of our professional societies to collaborate and address the gaps that exist across specialties.”

Can’t Miss Sessions:

  • Pharmacology Essentials for Cardio-Oncology Practice
  • How to Build and Grow a Cardio-Oncology Program
  • The Global Burden and Significance of Cancer and Cardiovascular Disease
  • Cardiovascular Disparities in Cancer Patients and Survivors: Strategies to Implement Inclusive, Equitable Care
  • Physical Activity Interventions in Our Cancer Patients and Survivors: Why, When, and How?

Posters

The following abstract titles are a selection of posters being presented during the conference. All ACC Advancing the Cardiovascular Care of the Oncology Patients posters and abstracts are embargoed until Friday, April 14, 2023, at 9 a.m. ET.

  • Racial Disparities in Cardiotoxicity Following Cancer Treatment: A Systematic Review and Meta-Analysis
  • Assessment of Detectable Atherosclerosis on Computed Tomography Imaging in Breast Cancer Patients Entering Treatment
  • Prevalence of Statin Use and Dyslipidemia Screening for Secondary Cardiovascular Prevention in Patients with Cancer
  • SGLT2 Inhibitors are Associated with a Lower Risk of Malnutrition and Cachexia in Patients with Heart Failure Receiving Anthracycline Treatment
SourceAmerican College of Cardiology (ACC)

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

0
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

0
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

0
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330